{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:48:44Z","timestamp":1780066124964,"version":"3.54.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["242102310143"],"award-info":[{"award-number":["242102310143"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12033-024-01205-7","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T17:02:14Z","timestamp":1717088534000},"page":"2399-2410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunological Roles of\u00a0CCL18 in\u00a0Pan\u2011Cancer and\u00a0Its Potential Value in\u00a0Endometrial Cancer"],"prefix":"10.1007","volume":"67","author":[{"given":"Cangxue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengYuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caowei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2042-4535","authenticated-orcid":false,"given":"Xuhui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"1205_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016). Endometrial cancer. Lancet, 387, 1094\u20131108.","journal-title":"Lancet"},{"key":"1205_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216057","author":"V Capaci","year":"2023","unstructured":"Capaci, V., Monasta, L., Aloisio, M., Sommella, E., Salviati, E., Campiglia, P., Basilicata, M. G., Kharrat, F., Licastro, D., Di Lorenzo, G., & Romano, F. (2023). A Multi-omics approach revealed common dysregulated pathways in type one and type two endometrial cancers. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms242216057","journal-title":"International Journal of Molecular Sciences"},{"key":"1205_CR3","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7\u201334.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1205_CR4","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1007\/s13277-015-3143-6","volume":"36","author":"X Li","year":"2015","unstructured":"Li, X., Zheng, S., Chen, S., Qin, F., Lau, S., & Chen, Q. (2015). Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Tumour Biology, 36, 4961\u20134966.","journal-title":"Tumour Biology"},{"key":"1205_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ygyno.2018.05.015","volume":"150","author":"RC Arend","year":"2018","unstructured":"Arend, R. C., Jones, B. A., Martinez, A., & Goodfellow, P. (2018). Endometrial cancer: Molecular markers and management of advanced stage disease. Gynecologic Oncology, 150, 569\u2013580.","journal-title":"Gynecologic Oncology"},{"key":"1205_CR6","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1001\/jamainternmed.2018.2819","volume":"178","author":"KA Matteson","year":"2018","unstructured":"Matteson, K. A., Robison, K., & Jacoby, V. L. (2018). Opportunities for early detection of endometrial cancer in women with postmenopausal bleeding. JAMA Internal Medicine, 178, 1222\u20131223.","journal-title":"JAMA Internal Medicine"},{"key":"1205_CR7","first-page":"445","volume":"73","author":"M Fillon","year":"2023","unstructured":"Fillon, M. (2023). Adding immunotherapy to chemotherapy improves survival for endometrial cancer patients. CA: A Cancer Journal for Clinicians, 73, 445\u2013447.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1205_CR8","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.annonc.2024.02.006","volume":"35","author":"G Bogani","year":"2024","unstructured":"Bogani, G., Monk, B. J., Powell, M. A., Westin, S. N., Slomovitz, B., Moore, K. N., Eskander, R. N., Raspagliesi, F., Barretina-Ginesta, M. P., Colombo, N., & Mirza, M. R. (2024). Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer. Annals of Oncology, 35, 414\u2013428.","journal-title":"Annals of Oncology"},{"key":"1205_CR9","first-page":"1341","volume":"329","author":"E Harris","year":"2023","unstructured":"Harris, E. (2023). Pembrolizumab immunotherapy improved endometrial cancer survival. JAMA, 329, 1341.","journal-title":"JAMA"},{"key":"1205_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jri.2014.12.006","volume":"109","author":"A Vanderstraeten","year":"2015","unstructured":"Vanderstraeten, A., Tuyaerts, S., & Amant, F. (2015). The immune system in the normal endometrium and implications for endometrial cancer development. Journal of Reproductive Immunology, 109, 7\u201316.","journal-title":"Journal of Reproductive Immunology"},{"key":"1205_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fonc.2020.00156","volume":"10","author":"V Bruno","year":"2020","unstructured":"Bruno, V., Corrado, G., Baci, D., Chiofalo, B., Carosi, M. A., Ronchetti, L., Piccione, E., Albini, A., Noonan, D. M., Piaggio, G., & Vizza, E. (2020). Endometrial cancer immune escape mechanisms: Let us learn from the fetal-maternal interface. Frontiers in Oncology, 10, 156.","journal-title":"Frontiers in Oncology"},{"key":"1205_CR12","first-page":"1","volume":"40","author":"AK Green","year":"2020","unstructured":"Green, A. K., Feinberg, J., & Makker, V. (2020). A Review of immune checkpoint blockade therapy in endometrial cancer. American Society of Clinical Oncology Educational Book, 40, 1\u20137.","journal-title":"American Society of Clinical Oncology Educational Book"},{"key":"1205_CR13","doi-asserted-by":"publisher","first-page":"990","DOI":"10.2174\/1389201020666181127152605","volume":"19","author":"M Op\u0142awski","year":"2018","unstructured":"Op\u0142awski, M., Dziobek, K., Adwent, I., D\u0105bru\u015b, D., Grabarek, B., Zmarz\u0142y, N., Plewka, A., & Boro\u0144, D. (2018). Expression profile of endoglin in different grades of endometrial cancer. Current Pharmaceutical Biotechnology, 19, 990\u2013995.","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"1205_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fonc.2013.00139","volume":"3","author":"JI Risinger","year":"2013","unstructured":"Risinger, J. I., Allard, J., Chandran, U., Day, R., Chandramouli, G. V., Miller, C., Zahn, C., Oliver, J., Litzi, T., Marcus, C., & Dubil, E. (2013). Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion. Frontiers in Oncology, 3, 139.","journal-title":"Frontiers in Oncology"},{"key":"1205_CR15","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-19-1382","volume":"80","author":"AC Rodriguez","year":"2020","unstructured":"Rodriguez, A. C., Vahrenkamp, J. M., Berrett, K. C., Clark, K. A., Guillen, K. P., Scherer, S. D., Yang, C. H., Welm, B. E., Jan\u00e1t-Amsbury, M. M., Graves, B. J., & Gertz, J. (2020). ETV4 Is Necessary for estrogen signaling and growth in endometrial cancer cells. Cancer Research., 80, 1234\u20131245.","journal-title":"Cancer Research."},{"key":"1205_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236011","author":"E Hermyt","year":"2019","unstructured":"Hermyt, E., Zmarzly, N., Grabarek, B., Kruszniewska-Rajs, C., Gola, J., Jeda-Golonka, A., Szczepanek, K., Mazurek, U., & Witek, A. (2019). Interplay between miRNAs and genes associated with cell proliferation in endometrial cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms20236011","journal-title":"International Journal of Molecular Sciences"},{"key":"1205_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1471-2105-12-213","volume":"12","author":"RS Day","year":"2011","unstructured":"Day, R. S., McDade, K. K., Chandran, U. R., Lisovich, A., Conrads, T. P., Hood, B. L., Kolli, V. S., Kirchner, D., Litzi, T., & Maxwell, G. L. (2011). Identifier mapping performance for integrating transcriptomics and proteomics experimental results. BMC Bioinformatics, 12, 213.","journal-title":"BMC Bioinformatics"},{"key":"1205_CR18","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47, W556\u2013W560.","journal-title":"Nucleic Acids Research"},{"key":"1205_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park, S. J., Yoon, B. H., Kim, S. K., & Kim, S. Y. (2019). GENT2: An updated gene expression database for normal and tumor tissues. BMC Medical Genomics, 12, 101.","journal-title":"BMC Medical Genomics"},{"key":"1205_CR20","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T., Fu, J., Zeng, Z., Cohen, D., Li, J., Chen, Q., Li, B., & Liu, X. S. (2020). TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Research, 48, W509\u2013W514.","journal-title":"Nucleic Acids Research"},{"key":"1205_CR21","first-page":"3792","volume":"18","author":"HL Li","year":"2019","unstructured":"Li, H. L., Sun, J. J., Ma, H., Liu, S. J., Li, N., Guo, S. J., Shi, Y., Xu, Y. Y., Qi, Z. Y., Wang, Y. Q., & Wang, F. (2019). MicroRNA-23a inhibits endometrial cancer cell development by targeting SIX1. Oncology letters, 18, 3792\u20133802.","journal-title":"Oncology letters"},{"key":"1205_CR22","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1158\/1541-7786.MCR-19-0475","volume":"17","author":"AA Suen","year":"2019","unstructured":"Suen, A. A., Jefferson, W. N., Wood, C. E., & Williams, C. J. (2019). SIX1 Regulates aberrant endometrial epithelial cell differentiation and cancer latency following developmental estrogenic chemical exposure. Molecular Cancer Research, 17, 2369\u20132382.","journal-title":"Molecular Cancer Research"},{"key":"1205_CR23","doi-asserted-by":"publisher","first-page":"101042831770621","DOI":"10.1177\/1010428317706217","volume":"39","author":"B Gong","year":"2017","unstructured":"Gong, B., Yue, Y., Wang, R., Zhang, Y., Jin, Q., & Zhou, X. (2017). Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells. Tumour Biology, 39, 1010428317706217.","journal-title":"Tumour Biology"},{"key":"1205_CR24","doi-asserted-by":"publisher","first-page":"4584250","DOI":"10.1155\/2020\/4584250","volume":"2020","author":"P Sadlecki","year":"2020","unstructured":"Sadlecki, P., Jozwicki, J., Antosik, P., & Walentowicz-Sadlecka, M. (2020). Expression of selected epithelial-mesenchymal transition transcription factors in endometrial cancer. BioMed Research International, 2020, 4584250.","journal-title":"BioMed Research International"},{"key":"1205_CR25","doi-asserted-by":"publisher","first-page":"e0206665","DOI":"10.1371\/journal.pone.0206665","volume":"13","author":"K Kusonmano","year":"2018","unstructured":"Kusonmano, K., Halle, M. K., Wik, E., Hoivik, E. A., Krakstad, C., Mauland, K. K., Tangen, I. L., Berg, A., Werner, H. M., Trovik, J., & \u00d8yan, A. M. (2018). Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer. PLoS ONE, 13, e0206665.","journal-title":"PLoS ONE"},{"key":"1205_CR26","first-page":"258","volume":"69","author":"RA Brooks","year":"2019","unstructured":"Brooks, R. A., Fleming, G. F., Lastra, R. R., Lee, N. K., Moroney, J. W., Son, C. H., Tatebe, K., & Veneris, J. L. (2019). Current recommendations and recent progress in endometrial cancer. CA: A Cancer Journal for Clinicians, 69, 258\u2013279.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1205_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.6004\/jnccn.2017.7066","volume":"16","author":"R Murali","year":"2018","unstructured":"Murali, R., Delair, D. F., Bean, S. M., Abu-Rustum, N. R., & Soslow, R. A. (2018). Evolving roles of histologic evaluation and molecular\/genomic profiling in the management of endometrial cancer. Journal of the National Comprehensive Cancer Network, 16, 201\u2013209.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"1205_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/cr.2016.157","volume":"27","author":"RL Sabado","year":"2017","unstructured":"Sabado, R. L., Balan, S., & Bhardwaj, N. (2017). Dendritic cell-based immunotherapy. Cell Research, 27, 74\u201395.","journal-title":"Cell Research"},{"key":"1205_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nri.2017.131","volume":"18","author":"Z Hu","year":"2018","unstructured":"Hu, Z., Ott, P. A., & Wu, C. J. (2018). Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nature Reviews Immunology, 18, 168\u2013182.","journal-title":"Nature Reviews Immunology"},{"key":"1205_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/1078-0432.CCR-14-3175","volume":"22","author":"A Desrichard","year":"2016","unstructured":"Desrichard, A., Snyder, A., & Chan, T. A. (2016). Cancer neoantigens and applications for immunotherapy. Clinical Cancer Research, 22, 807\u2013812.","journal-title":"Clinical Cancer Research"},{"key":"1205_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s41065-021-00193-x","volume":"158","author":"H Zhang","year":"2021","unstructured":"Zhang, H., & Chen, Y. (2021). Identification of glioblastoma immune subtypes and immune landscape based on a large cohort. Hereditas, 158, 30.","journal-title":"Hereditas"},{"key":"1205_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin, P., Toor, S. M., Sasidharan Nair, V., & Elkord, E. (2018). Immune checkpoint inhibitors: Recent progress and potential biomarkers. Experimental & Molecular Medicine, 50, 1\u201311.","journal-title":"Experimental & Molecular Medicine"},{"key":"1205_CR33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/42716","volume":"387","author":"GJ Adema","year":"1997","unstructured":"Adema, G. J., Hartgers, F., Verstraten, R., de Vries, E., Marland, G., Menon, S., Foster, J., Xu, Y., Nooyen, P., McClanahan, T., & Bacon, K. B. (1997). A dendritic-cell-derived C\u2013C chemokine that preferentially attracts naive T cells. Nature, 387, 713\u2013717.","journal-title":"Nature"},{"key":"1205_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217955","author":"J Korbecki","year":"2020","unstructured":"Korbecki, J., Olbromski, M., & Dziegiel, P. (2020). CCL18 in the progression of cancer. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21217955","journal-title":"International Journal of Molecular Sciences"},{"key":"1205_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41419-018-0486-0","volume":"9","author":"H Ye","year":"2018","unstructured":"Ye, H., Zhou, Q., Zheng, S., Li, G., Lin, Q., Wei, L., Fu, Z., Zhang, B., Liu, Y., Li, Z., & Chen, R. (2018). Tumor-associated macrophages promote progression and the Warburg effect via CCL18\/NF-kB\/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Cell Death & Disease, 9, 453.","journal-title":"Cell Death & Disease"},{"key":"1205_CR36","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12885-020-07073-z","volume":"20","author":"X Jiang","year":"2020","unstructured":"Jiang, X., Huang, Z., Sun, X., Zheng, X., Liu, J., Shen, J., Jia, B., Luo, H., Mai, Z., Chen, G., & Zhao, J. (2020). CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2\/STAT3 signaling pathway. BMC Cancer, 20, 632.","journal-title":"BMC Cancer"},{"key":"1205_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen, J., Yao, Y., Gong, C., Yu, F., Su, S., Chen, J., Liu, B., Deng, H., Wang, F., Lin, L., & Yao, H. (2011). CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell, 19, 541\u2013555.","journal-title":"Cancer Cell"},{"key":"1205_CR38","first-page":"5331","volume":"34","author":"R Sakane","year":"2014","unstructured":"Sakane, R., Tsubamoto, H., Sakata, K., Inoue, K., Ogino, M., Shibahara, H., Hao, H., & Hirota, S. (2014). Expression of chemokine ligand 18 in stage IA low-grade endometrial cancer. Anticancer Research, 34, 5331\u20135336.","journal-title":"Anticancer Research"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01205-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01205-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:47:29Z","timestamp":1746506849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01205-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1205"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01205-7","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}